Latest Intelligence

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
NewsWire
NewsWire

AmSurg reports higher Q4 net earnings, provides Q1 guidance

AmSurg Corp., an owner and operator of ambulatory surgery centers, has reported that net earnings attributable to the company's common shareholders for the fourth quarter ended December 31, 2014 were $25.11 million, or $0.53 per diluted share, compared to $19.56 million, or $0.61 per diluted share, for the same quarter ended December 31, 2013. For the first quarter of 2015, the company expects adjusted EPS to be in the range of $0.55 to $0.58.

Published By MarketLine
03 Mar 2015
NewsWire
NewsWire

Jazz reports higher Q4 net income, provides guidance for 2015

Jazz Pharmaceuticals plc, a specialty biopharmaceutical company, has reported that net income attributable to the company for the fourth quarter ended December 31, 2014 was $81.61 million, or $1.30 per diluted share, compared to $55.29 million, or $0.90 per diluted share, for the same quarter ended December 31, 2013. For 2015, the company expects GAAP net income attributable to the company to be between $5.17 and $5.70 per diluted share.

Published By MarketLine
03 Mar 2015
NewsWire
NewsWire

Nektar Therapeutics Q4 net loss down

Nektar Therapeutics, a clinical-stage biopharmaceutical company, has reported that net loss for the fourth quarter ended December 31, 2014 was $45.68 million, or $0.35 loss per share, compared to a net loss of $47.66 million, or $0.41 loss per share, for the same quarter ended December 31, 2013.

Published By MarketLine
03 Mar 2015
NewsWire
NewsWire

WebMD Health reports higher Q4 net income, provides Q1 guidance

WebMD Health Corp., a provider of health information services, has reported that net income for the fourth quarter ended December 31, 2014 was $16.28 million, or $0.38 per diluted share, compared to $10.81 million, or $0.25 per diluted share, for the same quarter ended December 31, 2013. For first quarter of 2015, the company expects net income to be approximately $8.5 million to $9.5 million.

Published By MarketLine
03 Mar 2015
NewsWire
NewsWire

Almost Family Q4 net income up

Almost Family, Inc., a provider of home health services, has reported that net income attributable to the company for the fourth quarter ended December 31, 2014 was $4.75 million, or $0.50 per diluted share, compared to $328,000, or $0.03 per diluted share, for the same quarter ended December 31, 2013.

Published By MarketLine
03 Mar 2015
NewsWire
NewsWire

Insulet to assume distribution rights for insulin management system in Canada

Insulet Corporation, a medical device company, has announced that following a four year distribution agreement with GlaxoSmithKline, or GSK, the company will assume full rights to distribute the OmniPod System in the Canadian market via a newly created Canadian Subsidiary, Insulet Canada Corporation.

Published By MarketLine
03 Mar 2015
NewsWire
NewsWire

Alkermes reports higher Q4 net income, provides guidance for 2015

Alkermes plc, a biopharmaceutical company, has reported that net income for the fourth quarter ended December 31, 2014 was $30.51 million, or $0.20 per diluted share, compared to $18.08 million, or $0.12 per diluted share, for the same quarter ended December 31, 2013. For 2015, the company expects GAAP net loss to be in the range of $255 million to $285 million, or a basic and diluted loss per share of $1.70 to $1.90.

Published By MarketLine
03 Mar 2015
NewsWire
NewsWire

Infinity Pharmaceuticals Q4 net loss up

Infinity Pharmaceuticals, Inc., a biopharmaceutical company, has reported that net loss for the fourth quarter ended December 31, 2014 was $40.34 million, or $0.83 loss per share, compared to a net loss of $32.92 million, or $0.68 loss per share, for the same quarter ended December 31, 2013.

Published By MarketLine
03 Mar 2015
NewsWire
NewsWire

Healthways reports net income for Q4, provides guidance for 2015

Healthways, Inc., a provider of well-being improvement solutions, has reported that net income for the fourth quarter ended December 31, 2014 was $2.58 million, or $0.07 per share, compared to a net loss of $5.29 million, or $0.15 loss per share, for the same quarter ended December 31, 2013. For 2015, the company expects net earnings per diluted share to be in the range of $0.23 to 0.35 and adjusted net earnings per diluted share to be $0.35 to 0.47.

Published By MarketLine
03 Mar 2015
NewsWire
NewsWire

Nuffield re-launches health and wellbeing center in Tunbridge Wells

The Nuffield Health has re-launched the Nuffield Health Fitness & Wellbeing Centre in Tunbridge Wells.

Published By MarketLine
02 Mar 2015

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.